Catalyst Wire Dossier Catalyst Wire Dossier

FLUTICASONE PROPIONATE ALLERGY RELIEF

FLUTICASONE PROPIONATE · GLENMARK THERAPEUTICS INC., USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FLUTICASONE PROPIONATE ALLERGY RELIEF, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: FDA Approved: FLUTICASONE PROPIONATE ALLERGY RELIEF — Original Application (GLENMARK THERAPEUTICS INC., USA)

See pricing